Cargando…
Glucose–insulin–potassium therapy in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials
BACKGROUND: Glucose-insulin-potassium (GIK) has been advocated in the setting of acute coronary syndrome (ACS) to reduce ischemia-related arrhythmias and myocardial injury. We conducted a meta-analysis of randomized controlled trials (RCTs) to assess whether the use of GIK infusions >3 or <3 h...
Autores principales: | Jin, Pei-Yin, Zhang, Hai-San, Guo, Xiao-Yan, Liang, Wei-Fang, Han, Qin-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4256054/ https://www.ncbi.nlm.nih.gov/pubmed/25425404 http://dx.doi.org/10.1186/1471-2261-14-169 |
Ejemplares similares
-
One‐Year Outcome of Intensive Insulin Therapy Combined to Glucose‐Insulin‐Potassium in Acute Coronary Syndrome: A Randomized Controlled Study
por: Bouida, Wahid, et al.
Publicado: (2017) -
C-Reactive protein reactions to glucose-insulin-potassium infusion and relations to infarct size in patients with acute coronary syndromes
por: Alkofide, Hadeel, et al.
Publicado: (2015) -
Possible increase in insulin resistance and concealed glucose-coupled potassium-lowering mechanisms during acute coronary syndrome documented by covariance structure analysis
por: Ito, Satoshi, et al.
Publicado: (2017) -
The role of insulin therapy and glucose normalisation in patients with acute coronary syndrome
por: Lipton, J. A., et al.
Publicado: (2011) -
Pretreatment with glucose–insulin–potassium improves ventricular performances after coronary artery bypass surgery: a randomized controlled trial
por: Licker, Marc, et al.
Publicado: (2019)